Skip to main content
Withus Pharmaceutical. Co., LTD logo

Withus Pharmaceutical. Co., LTD — Investor Relations & Filings

Ticker · 330350 ISIN · KR7330350000 KO Manufacturing
Open in API
Filings indexed 119 across all filing types
Latest filing 2021-02-25 Notice of Dividend Amou…
Country KR South Korea
Listing KO 330350

About Withus Pharmaceutical. Co., LTD

https://withuspharm.com/

Withus Pharmaceutical. Co., LTD. is a pharmaceutical company engaged in the manufacturing and sale of prescription drugs. The company's product portfolio addresses a range of therapeutic areas, with a focus on circulatory agents, endocrine system treatments, and musculoskeletal drugs. Additionally, its offerings include antibiotics and medications for allergies.

Recent filings

Filing Released Lang Actions
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 1% confidence The document is a formal announcement from Withers Pharmaceutical regarding the decision to pay a cash dividend. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the board resolution. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2021-02-25 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (Withus Pharmaceutical) announcing a significant change in revenue or profit structure (exceeding 15% for large corporations or 30% for others). This is a standard regulatory disclosure requirement in the Korean market (DART system) for material financial events. Since it provides the initial announcement of financial results and the reasons for the variance, it falls under the 'Earnings Release' category as it serves as the primary notification of financial performance highlights. FY 2020
2021-02-10 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory notice regarding the suspension of share registration (closing of the shareholder register) for Withers Pharmaceutical. It specifies the record date and the purpose, which is to determine shareholders for the upcoming 17th Annual General Meeting. Since it is a regulatory announcement regarding corporate administrative procedures and does not fit into specific categories like dividend announcements or proxy solicitations, it is classified as a general regulatory filing.
2020-12-16 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for Withus Pharmaceutical Co., Ltd. for the period of 2020-07-01 to 2020-09-30. It contains detailed company information, business descriptions, financial data, and management disclosures, which are characteristic of a formal quarterly financial report. It is not an announcement of a report (RPA) or a simple certification (RNS), but the full report itself. Q3 2020
2020-11-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically a decrease in holdings by Mirae Equity Partners in Withus Pharmaceutical) due to market transactions. This falls under the category of 'Major Shareholding Notification' (MRQ), as it tracks significant changes in ownership levels that require regulatory disclosure.
2020-10-08 Korean
사업보고서 (2020.06)
Annual Report Classification · 1% confidence The document is a comprehensive 'Business Report' (사업보고서) for Withus Pharmaceutical Co., Ltd. for the fiscal year ending June 30, 2020. It contains detailed sections on company overview, history, capital changes, shareholder information, and business operations. This structure and content align with the regulatory requirements for an annual financial report in South Korea, which is equivalent to a 10-K filing in the US market. FY 2019
2020-09-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.